SCHEMBL7449489

SCHEMBL7449489

CC(C)CCCOc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.62
HPGD P15428 1/20 0.57
TDP1 Q9NUW8 2/20 0.54
HTR1B P28222 2/20 0.53
LTA4H P09960 2/20 0.53
RARB P10826 1/20 0.51
TAAR1 Q96RJ0 1/20 0.50
MAPK1 P28482 1/20 0.50
ALDH1A1 P00352 1/20 0.50
RECQL P46063 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11580701 0.94 KCNA3 (0.67) KCNA3HPGDTDP1HTR1BLTA4H
SCHEMBL17286562 0.92 LTA4H (0.67) KCNA3HPGDTDP1LTA4HRARB
SCHEMBL12746095 0.92 KCNA3 (0.64) KCNA3HPGDTDP1HTR1BLTA4H
SCHEMBL11068531 0.92 KCNA3 (0.64) KCNA3HPGDTDP1HTR1BLTA4H
SCHEMBL358609 0.92 KCNA3 (0.64) KCNA3HPGDTDP1HTR1BLTA4H
SCHEMBL29394668 0.90 KCNA3 (0.61) KCNA3HPGDTDP1HTR1BLTA4H
SCHEMBL195569 0.89 TDP1 (0.64) KCNA3HPGDTDP1HTR1BLTA4H
Ethylene SCHEMBL28162451 0.88 KCNA3 (0.59) KCNA3HPGDTDP1HTR1BLTA4H
SCHEMBL13251245 0.88 RARB (0.62) KCNA3TDP1RARBMAPK1HDAC3
Ammonia Solution, Strong SCHEMBL8909905 0.87 TDP1 (0.62) KCNA3HPGDTDP1HTR1BLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119656881-B Reverse osmosis membrane with coralloid structure and preparation method and application thereof 苏州实验室 2025-05-23 CN claimed
CN-119656881-A Reverse osmosis membrane with coralloid structure and preparation method and application thereof 苏州实验室 2025-03-21 CN claimed
CN-105491991-A Cosmetic compositions MARY KAY INC 2016-04-13 CN claimed
CN-101528273-B Perfume composition for expressing the fragrance of ume flowers AMOREPACIFIC CORP 2013-08-14 CN claimed
CN-101528273-A Perfume composition for expressing the fragrance of ume flowers AMOREPACIFIC CORP (KR) 2009-09-09 CN claimed
CN-1070848-C Sulfonate derivatized perfumes PROCTER & GAMBLES CO (US) 2001-09-12 CN claimed
CN-1209164-A Sulfonate perfumes for laundry and cleaning composition PROCTER & GAMBLE (US) 1999-02-24 CN claimed
CN-1209118-A Sulfonate derivatized perfumes PROCTER & GAMBLE (US) 1999-02-24 CN claimed
CN-119656881-B Reverse osmosis membrane with coralloid structure and preparation method and application thereof 苏州实验室 2025-05-23 CN disclosed
CN-119656881-A Reverse osmosis membrane with coralloid structure and preparation method and application thereof 苏州实验室 2025-03-21 CN disclosed
US-20230212195-A1 COMPOUNDS, CONJUGATES, AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-07-06 US disclosed
EP-3849968-B1 1H-INDAZOLE CARBOXAMIDES AS RECEPTOR-INTERACTING PROTEIN KINASE 1 INHIBITORS (RIPK1) BRISTOL MYERS SQUIBB CO (US) 2022-12-21 EP disclosed
US-10844032-B2 Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors VANDERBILT UNIVERSITY (US) 2020-11-24 US disclosed
EP-2955575-B1 RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, AND POLYPHENOL DERIVATIVE USED IN SAME MITSUBISHI GAS CHEMICAL CO (JP) 2020-07-29 EP disclosed
CN-1209118-A Sulfonate derivatized perfumes PROCTER & GAMBLE (US) 1999-02-24 CN disclosed
WO-1998049152-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1998-11-05 WO disclosed
US-4837301-A FROM ALKALI MTEAL SULFIDES AND AROMATIC DIHALOGEN COMPOUNDS; IMPROVED CORROSION RESISTANCE BAYER AKTIENGESELLSCHAFT (DE) 1989-06-06 US disclosed
EP-0275007-A2 Process for the preparation of highly molecular, optionally branched polyarylene sulfides BAYER AG (DE) 1988-07-20 EP disclosed
US-4428889-A PREPARING THIOPEPTIDES FROM PEPTIDES BRISTOL-MYERS COMPANY (US) 1984-01-31 US disclosed
US-4066707-A METHOD FOR MANUFACTURE OF DIPHENOLS AND MONOALKYL ETHERS OF DIPHENOLS AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JA) 1978-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212195-A1 COMPOUNDS, CONJUGATES, AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES AND USES THEREOF DNPEP, DHPS, NPEPPS KCNA3 736/4885HPGD 465/4885TDP1 2318/4885
US-10844032-B2 Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors MCL1, BCL2L1, BCLAF1 KCNA3 2798/4885HPGD 3486/4885TDP1 1486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.